Neryzur (Amlodipine Besilate, Nebivolol Hydrochloride)

Neryzur, a combination of a calcium channel blocker and a beta‑blocker, is used to manage elevated blood pressure.

• Essential hypertension: lowers both systolic and diastolic blood pressure and reduces cardiovascular risk.
• Isolated systolic hypertension: provides vasodilation while controlling heart rate.
• Hypertension with high cardiovascular risk: improves endothelial function and helps lower overall risk.

• Amlodipine besilate blocks L‑type calcium channels in vascular smooth muscle, causing arterial relaxation and reduced peripheral resistance. Nebivolol hydrochloride selectively antagonises β1‑adrenergic receptors, decreasing heart rate and contractility, while also stimulating nitric‑oxide release for additional vasodilation, together producing an additive antihypertensive effect.

Adverse reactions may occur with Neryzur and are categorized by frequency.

Common Side Effects

• Headache: mild to moderate intensity.
• Peripheral edema: swelling of ankles or lower limbs.
• Dizziness or light‑headedness: especially after standing.
• Flushing: transient warmth and redness.
• Fatigue: general tiredness.
• Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Bradycardia: abnormally slow heart rate.
• Heart block: impaired electrical conduction.
• Angioedema: swelling of face, lips, or throat.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Allergic reactions: rash, itching, or anaphylaxis.

Before initiating Neryzur, clinicians should consider several safety factors.

• Blood pressure monitoring: assess baseline and follow‑up readings.
• Heart failure: use with caution and monitor fluid status.
• Severe hepatic impairment: dose adjustment may be required.
• Pregnancy and lactation: evaluate risk‑benefit and consult a specialist.
• Concomitant medications: review for potential interactions.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Neryzur may interact with other medicines; awareness of interaction severity guides management.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase plasma concentrations of amlodipine.
• Co‑administration with other potent antihypertensives (e.g., ACE inhibitors, ARBs) may cause excessive hypotension.
• Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem) with nebivolol can precipitate bradycardia.

Moderate Interactions (Monitor Closely)

• Beta‑agonist bronchodilators (e.g., albuterol): may reduce nebivolol efficacy.
• Loop or thiazide diuretics: monitor electrolytes and blood pressure.
• Alcohol: can enhance hypotensive effect, requiring caution.